Global Age Related Macular Degeneration Drug Market Research Report Forecast 2017-2021

May 2017 | 110 pages | ID: GC597FCD371EN
S&P Consulting

Abstracts

The Global Age Related Macular Degeneration Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Age Related Macular Degeneration Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Age Related Macular Degeneration Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

Global Age Related Macular Degeneration Drug Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:

Roche/Genentech
Novartis
Regeneron
Bayer
Valeant
Allergan
Alimera Sciences
Ophthotech
Acucela

Global Age Related Macular Degeneration Drug Market: Product Segment Analysis

Type 1
Type 2
Type 3


Global Age Related Macular Degeneration Drug Market: Application Segment Analysis

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Global Age Related Macular Degeneration Drug Market Research Report Forecast 2017-2021

CHAPTER 1 AGE RELATED MACULAR DEGENERATION DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Age Related Macular Degeneration Drug Market Segmentation by Type
  1.2.1 Global Production Market Share of Age Related Macular Degeneration Drug by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Age Related Macular Degeneration Drug Market Segmentation by Application
  1.3.1 Age Related Macular Degeneration Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Age Related Macular Degeneration Drug Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Age Related Macular Degeneration Drug (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON AGE RELATED MACULAR DEGENERATION DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 Global Age Related Macular Degeneration Drug Production and Share by Manufacturers (2015 and 2016)
3.2 Global Age Related Macular Degeneration Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Age Related Macular Degeneration Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Age Related Macular Degeneration Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Age Related Macular Degeneration Drug Market Competitive Situation and Trends
  3.5.1 Age Related Macular Degeneration Drug Market Concentration Rate
  3.5.2 Age Related Macular Degeneration Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Age Related Macular Degeneration Drug Production by Region (2012-2017)
4.2 Global Age Related Macular Degeneration Drug Production Market Share by Region (2012-2017)
4.3 Global Age Related Macular Degeneration Drug Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Age Related Macular Degeneration Drug Consumption by Regions (2012-2017)
5.2 North America Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Age Related Macular Degeneration Drug Production and Market Share by Type (2012-2017)
6.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2012-2017)
6.3 Global Age Related Macular Degeneration Drug Price by Type (2012-2017)
6.4 Global Age Related Macular Degeneration Drug Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MARKET ANALYSIS BY APPLICATION

7.1 Global Age Related Macular Degeneration Drug Consumption and Market Share by Application (2012-2017)
7.2 Global Age Related Macular Degeneration Drug Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURERS ANALYSIS

8.1 Roche/Genentech
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Novartis
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Regeneron
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Bayer
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Valeant
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Allergan
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Alimera Sciences
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Ophthotech
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Acucela
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURING COST ANALYSIS

9.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MARKET FORECAST (2017-2021)

13.1 Global Age Related Macular Degeneration Drug Production, Revenue Forecast (2017-2021)
13.2 Global Age Related Macular Degeneration Drug Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Age Related Macular Degeneration Drug Production Forecast by Type (2017-2021)
13.4 Global Age Related Macular Degeneration Drug Consumption Forecast by Application (2017-2021)
13.5 Age Related Macular Degeneration Drug Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Age Related Macular Degeneration Drug
Figure Global Production Market Share of Age Related Macular Degeneration Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Age Related Macular Degeneration Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Age Related Macular Degeneration Drug Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Age Related Macular Degeneration Drug Capacity of Key Manufacturers (2015 and 2016)
Table Global Age Related Macular Degeneration Drug Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Age Related Macular Degeneration Drug Capacity of Key Manufacturers in 2015
Figure Global Age Related Macular Degeneration Drug Capacity of Key Manufacturers in 2016
Table Global Age Related Macular Degeneration Drug Production of Key Manufacturers (2015 and 2016)
Table Global Age Related Macular Degeneration Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Age Related Macular Degeneration Drug Production Share by Manufacturers
Figure 2016 Age Related Macular Degeneration Drug Production Share by Manufacturers
Table Global Age Related Macular Degeneration Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table 2016 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table Global Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Age Related Macular Degeneration Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Age Related Macular Degeneration Drug Product Type
Figure Age Related Macular Degeneration Drug Market Share of Top 3 Manufacturers
Figure Age Related Macular Degeneration Drug Market Share of Top 5 Manufacturers
Table Global Age Related Macular Degeneration Drug Capacity by Regions (2012-2017)
Figure Global Age Related Macular Degeneration Drug Capacity Market Share by Regions (2012-2017)
Figure Global Age Related Macular Degeneration Drug Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Age Related Macular Degeneration Drug Capacity Market Share by Regions
Table Global Age Related Macular Degeneration Drug Production by Regions (2012-2017)
Figure Global Age Related Macular Degeneration Drug Production and Market Share by Regions (2012-2017)
Figure Global Age Related Macular Degeneration Drug Production Market Share by Regions (2012-2017)
Figure 2015 Global Age Related Macular Degeneration Drug Production Market Share by Regions
Table Global Age Related Macular Degeneration Drug Revenue by Regions (2012-2017)
Table Global Age Related Macular Degeneration Drug Revenue Market Share by Regions (2012-2017)
Table 2015 Global Age Related Macular Degeneration Drug Revenue Market Share by Regions
Table Global Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table China Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table India Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Age Related Macular Degeneration Drug Consumption Market by Regions (2012-2017)
Table Global Age Related Macular Degeneration Drug Consumption Market Share by Regions (2012-2017)
Figure Global Age Related Macular Degeneration Drug Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Age Related Macular Degeneration Drug Consumption Market Share by Regions
Table North America Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017)
Table Europe Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017)
Table China Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017)
Table Japan Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017)
Table India Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017)
Table Global Age Related Macular Degeneration Drug Production by Type (2012-2017)
Table Global Age Related Macular Degeneration Drug Production Share by Type (2012-2017)
Figure Production Market Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure 2015 Production Market Share of Age Related Macular Degeneration Drug by Type
Table Global Age Related Macular Degeneration Drug Revenue by Type (2012-2017)
Table Global Age Related Macular Degeneration Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Age Related Macular Degeneration Drug by Type
Table Global Age Related Macular Degeneration Drug Price by Type (2012-2017)
Figure Global Age Related Macular Degeneration Drug Production Growth by Type (2012-2017)
Table Global Age Related Macular Degeneration Drug Consumption by Application (2012-2017)
Table Global Age Related Macular Degeneration Drug Consumption Market Share by Application (2012-2017)
Figure Global Age Related Macular Degeneration Drug Consumption Market Share by Application in 2015
Table Global Age Related Macular Degeneration Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Age Related Macular Degeneration Drug Consumption Growth Rate by Application (2012-2017)
Table Roche/Genentech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche/Genentech Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Roche/Genentech Age Related Macular Degeneration Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Age Related Macular Degeneration Drug Market Share (2012-2017)
Table Regeneron Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Regeneron Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Regeneron Age Related Macular Degeneration Drug Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Age Related Macular Degeneration Drug Market Share (2012-2017)
Table Valeant Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Valeant Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Valeant Age Related Macular Degeneration Drug Market Share (2012-2017)
Table Allergan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Allergan Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Age Related Macular Degeneration Drug Market Share (2012-2017)
Table Alimera Sciences Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Alimera Sciences Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Alimera Sciences Age Related Macular Degeneration Drug Market Share (2012-2017)
Table Ophthotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Ophthotech Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Ophthotech Age Related Macular Degeneration Drug Market Share (2012-2017)
Table Acucela Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Acucela Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Acucela Age Related Macular Degeneration Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure Global Age Related Macular Degeneration Drug Production and Growth Rate Forecast (2017-2021)
Figure Global Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Age Related Macular Degeneration Drug Production Forecast by Regions (2017-2021)
Table Global Age Related Macular Degeneration Drug Consumption Forecast by Regions (2017-2021)
Table Global Age Related Macular Degeneration Drug Production Forecast by Type (2017-2021)
Table Global Age Related Macular Degeneration Drug Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Roche/Genentech, Novartis, Regeneron, Bayer, Valeant, Allergan, Alimera Sciences, Ophthotech, Acucela, Ohr Pharmaceuticals